You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
艾迪药业(688488.SH):艾诺韦林原料药获得上市申请批准通知书
格隆汇 06-03 18:06

格隆汇6月3日丨艾迪药业(688488.SH)公布,公司全资子公司扬州艾迪医药科技有限公司(统称“艾迪药业”或“公司”)收到国家药品监督管理局签发的“艾诺韦林”《化学原料药上市申请批准通知书》(通知书编号:2024YS00494)。公司化学原料药艾诺韦林获得《化学原料药上市申请批准通知书》,表明该原料药已符合国家相关药品审评技术标准,已批准在国内制剂中使用,后续可应用于艾诺韦林片以及艾诺米替片的制剂生产,将进一步保障原料药供应与质量,降低生产成本,丰富公司产品线,提升公司核心竞争力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account